Overview

Trial of XELIRI/FOLFIRI + Simvastatin Followed by Simvastatin Maintenance in Metastatic Colorectal Cancer

Status:
Unknown status
Trial end date:
2014-05-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to compare 2nd line XELIRI/FOLFIRI + simvastatin vs XELIRI/FOLFIRI + placebo.
Phase:
Phase 3
Details
Lead Sponsor:
Samsung Medical Center
Treatments:
Simvastatin